Thrombogenic materials in prothrombin complex concentrates.
D000328:Adult; D001344:Autopsy; D001779:Blood Coagulation Factors / Q000009:adverse effects*; D001921:Brain / Q000473:pathology; D002540:Cerebral Cortex / Q000473:pathology; D003327:Coronary Disease / Q000139:chemically induced / Q000473:pathology; D003331:Coronary Vessels / Q000473:pathology; D004211:Disseminated Intravascular Coagulation / Q000139:chemically induced*; D004340:Drug Contamination; D005164:Factor IX / Q000009:adverse effects; D005170:Factor X / Q000009:adverse effects; D005260:Female; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000139:chemically induced / Q000473:pathology; D008099:Liver / Q000473:pathology; D008168:Lung / Q000473:pathology; D009206:Myocardium / Q000473:pathology; D011516:Prothrombin / Q000009:adverse effects*; D011651:Pulmonary Artery / Q000473:pathology; D011655:Pulmonary Embolism / Q000139:chemically induced / Q000473:pathology; D012077:Renal Artery / Q000473:pathology; D012078:Renal Artery Obstruction / Q000139:chemically induced / Q000473:pathology; D013923:Thromboembolism / Q000139:chemically induced*; D014599:Uterus / Q000473:pathology
D001779:Blood Coagulation Factors; D011516:Prothrombin; D005164:Factor IX; D005170:Factor X